The impact of polycystic ovary syndrome on placental histopathology patterns in in-vitro fertilization singleton live births.
暂无分享,去创建一个
J. Shaul | A. Volodarsky-Perel | M. Dahan | G. Mills | A. Hochberg | Tuyet Nhung Ton Nu | A. Machado-Gédéon | Yiming Cui
[1] J. Alijotas-Reig,et al. Chronic Villitis of unknown etiology (VUE): Obstetrical features, outcome and treatment. , 2021, Journal of reproductive immunology.
[2] D. Schust,et al. Placental structural abnormalities in gestational diabetes and when they develop: A scoping review. , 2021, Placenta.
[3] L. Giudice,et al. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. , 2020, Human reproduction update.
[4] G. Desoye,et al. Diabetes Mellitus, Obesity, and the Placenta. , 2020, Obstetrics and gynecology clinics of North America.
[5] V. Padmanabhan,et al. A narrative review of placental contribution to adverse pregnancy outcomes in women with polycystic ovary syndrome. , 2019, The Journal of clinical endocrinology and metabolism.
[6] L. Moran,et al. Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity—A systematic review, meta‐analysis, and meta‐regression , 2019, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[7] G. Reaven,et al. Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome , 2019, Endocrine.
[8] G. Reaven,et al. Relationship between surrogate estimates and direct measurement of insulin resistance in women with polycystic ovary syndrome , 2019, Journal of Endocrinological Investigation.
[9] L. Redman,et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome†‡ , 2018, Human reproduction.
[10] R. Redline,et al. Fetal vascular malperfusion, an update , 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[11] A. Heider. Fetal Vascular Malperfusion. , 2017, Archives of pathology & laboratory medicine.
[12] B. Tarlatzis,et al. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. , 2017, Metabolism: clinical and experimental.
[13] G. Reaven,et al. Cardiovascular disease in PCOS is related to severe insulin resistance, not mild. , 2017, Minerva Endocrinologica.
[14] M. P. Koster,et al. Increased rates of complications in singleton pregnancies of women previously diagnosed with polycystic ovary syndrome predominantly in the hyperandrogenic phenotype. , 2017, Fertility and sterility.
[15] S. Palomba,et al. Oocyte Competence in Women with Polycystic Ovary Syndrome , 2017, Trends in Endocrinology & Metabolism.
[16] S. Palomba,et al. Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review , 2016, Reproductive Biology and Endocrinology.
[17] R. Azziz,et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. , 2016, Fertility and sterility.
[18] Neil J Sebire,et al. Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement. , 2016, Archives of pathology & laboratory medicine.
[19] S. Jenkins-Jones,et al. Contemporary Reproductive Outcomes for Patients With Polycystic Ovary Syndrome: A Retrospective Observational Study , 2016, The Journal of clinical endocrinology and metabolism.
[20] B. Fauser,et al. Placental characteristics in women with polycystic ovary syndrome. , 2015, Human reproduction.
[21] B. Fauser,et al. Pregnancy complications in women with polycystic ovary syndrome. , 2015, Human reproduction update.
[22] F. Hirahara,et al. Circumvallate Placenta: Associated Clinical Manifestations and Complications—A Retrospective Study , 2014, Obstetrics and gynecology international.
[23] F. Zullo,et al. Early trophoblast invasion and placentation in women with different PCOS phenotypes. , 2014, Reproductive biomedicine online.
[24] Joselyn Rojas,et al. Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth , 2014, International journal of reproductive medicine.
[25] F. Zullo,et al. Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome. , 2013, Human reproduction.
[26] Mu-Jun Li,et al. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis , 2013, Reproductive Biology and Endocrinology.
[27] F. Zullo,et al. Decidual endovascular trophoblast invasion in women with polycystic ovary syndrome: an experimental case-control study. , 2012, The Journal of clinical endocrinology and metabolism.
[28] N. Sebire,et al. Frequency and clinical significance of placental histological lesions in an unselected population at or near term , 2011, Virchows Archiv.
[29] L. Sanchez-Ramos,et al. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. , 2011, American journal of obstetrics and gynecology.
[30] F. Orio,et al. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. , 2010, Fertility and sterility.
[31] R. Viscardi,et al. Discrepancy in pathologic diagnosis of placental lesions. , 2009, Archives of pathology & laboratory medicine.
[32] S. Marinopoulos,et al. Placental pathology in women with gestational diabetes , 2008, Acta obstetricia et gynecologica Scandinavica.
[33] Z. Calay,et al. The Incidence of Placental Abnormalities, Maternal and Cord Plasma Malondialdehyde and Vascular Endothelial Growth Factor Levels in Women with Gestational Diabetes Mellitus and Nondiabetic Controls , 2008, Gynecologic and Obstetric Investigation.
[34] Shunji Suzuki. Clinical significance of pregnancies with circumvallate placenta , 2007, The journal of obstetrics and gynaecology research.
[35] A. Franx,et al. Inflammatory Changes in Preeclampsia: Current Understanding of the Maternal Innate and Adaptive Immune Response , 2007, Obstetrical & gynecological survey.
[36] Richard S Legro,et al. Polycystic ovary syndrome , 2007, The Lancet.
[37] M. Eijkemans,et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. , 2006, Human reproduction update.
[38] R. Azziz. How prevalent is metabolic syndrome in women with polycystic ovary syndrome? , 2006, Nature Clinical Practice Endocrinology &Metabolism.
[39] R. Azziz. Diagnostic criteria for polycystic ovary syndrome: a reappraisal. , 2005, Fertility and sterility.
[40] S. Palomba,et al. Pregnancy complications in women with polycystic ovary syndrome: importance of diagnostic criteria or of phenotypic features? , 2016, Human reproduction.
[41] C. Sibley,et al. Obesity and the placenta: A consideration of nutrient exchange mechanisms in relation to aberrant fetal growth. , 2011, Placenta.
[42] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.